SEARCH

SEARCH BY CITATION

REFERENCES

  • Andresen BS, Bross P, Udvari S, Kirk J, Gray G, Kmoch S, Chamoles N, Knudsen I, Winter V, Wilcken B, Yokota I, Hart K, Packman S, Harpey JP, Saudubray JM, Hale DE, Bolund L, Kolvraa S, Gregersen N. 1997. The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype? Hum Mol Genet 6:695707.
  • Bross P, Jespersen C, Jensen TG, Andresen BS, Kristensen MJ, Winter V, Nandy A, Krautle F, Ghisla S, Bolundi L, Jung-Ja PK, Gregersen N. 1995. Effects of two mutations detected in medium chain acyl-CoA dehydrogenase (MCAD)-deficient patients on folding, oligomer assembly and stability of MCAD enzyme. J Biol Chem 270:1028410290.
  • Desviat LR, Perez B, Garcia MJ, Martínez-Pardo M, Baldellou A, Arena J, Sanjurjo P, Campistol J, Couce ML, Fernández A, Cardesa J, Ugarte M. 1997. Relationship between mutation genotype and biochemical phenotype in a heterogeneous Spanish phenylketonuria population. Eur J Hum Genet 5:196202.
  • Desviat LR, Perez B, Gámez A, Sánchez A, García MJ, Martínez-Pardo M, Marchante C, Bóveda D, Baldellou A, Arena J, Sanjurjo P, Fernández A, Cabello ML, Ugarte M. 1999. Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions. Eur J Hum Gen 7:386392.
  • Dworniczak B, Aulehla-Scholz C, Kalaydjieva L, Bartholome K, Grudda K, Horst J. 1991. Aberrant splicing of phenylalanine hydroxylase mRNA: the major cause for Phenylketonuria in parts of Southern Europe. Genomics 11:242946.
  • Eisensmith RC, Martinez DR, Kuzmin AI, Goltsov AA, Brown A, Singh R, Elsas LJ, Woo SL. 1995. Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population. Pediatrics 97:512516.
  • Erlandsen H, Fusetti F, Martinez A, Hough E, Flatmark T, Stevens RC. 1997. Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria. Nat Struct Biol 4:9951000.
  • Erlandsen H, Stevens RC. 1999. The structural basis of phenylketonuria. Mol Genet Metab 68:103125.
  • Erlandsen H, Stevens RC. 2001. A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria. J Inherit Metab Dis 24:213230.
  • Flatmark T, Stevens RC. 1999. Structural Iisight into the aromatic amino acid hydroxylases and their disease-related mutant forms. Chem Rev 99:21372160.
  • Fusetti F, Erlandsen H, Flatmark T, Stevens RC. 1998. Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J Biol Chem 273:1696216967.
  • Gamez A, Perez B, Ugarte M, Desviat LR. 2000. Expression analysis of phenylketonuria mutations: effect on folding and stability of the phenylalanine hydroxylase protein. J Biol Chem 275:2973729742.
  • Gjetting T, Petersen M, Guldberg P, Guttler F. 2001a. Missense mutations in the N-terminal domain of human phenylalanine hydroxylase interfere with binding of regulatory phenylalanine. Am J Hum Genet 68:13531360.
  • Gjetting T, Petersen M, Guldberg P, Güttler F. 2001b. In Vitro Expression of 34 naturally occurring mutant variants of phenylalanine hydroxylase: correlation with metabolic phenotypes and susceptibility toward protein aggregation. Mol Genet Metab 72:132143.
  • Gregersen N, Bross P, Andresen BS, Pedersen PL, Corydon MJ, Bolund L. 2001. The role of chaperone-assisted folding and quality control in inborn errors of metabolism:protein folding disorders. J Inherit Metab Dis 24:189212.
  • Guldberg P, Rey F, Zschocke J, Romano V, François B, Michiels L, Ullrich K, Hoffmann GF, Burgard P, Schmidt H, Meli C, Riva E, Dianzani I, Ponzone A, Rey J, Güttler F. 1998. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63:7179.
  • Jennings IG, Cotton RG, Kobe B. 2000. Structural interpretation of mutations in phenylalanine hydroxylase protein aids in identifying genotype-phenotype correlations in phenyl-ketonuria. Eur J Hum Genet 8:683696.
  • Jensen TG, Bross P, Andresen BS, Lund TB, Kristensen TJ, Jensen UB, Winther V, Kølvraa S, Gregersen N, LB. 1995. Comparison between medium-chain acyl-coA dehydrogenase mutant proteins overexpressed in bacterial and mammalian cells. Hum Mutat 6:226231.
  • Kobe B, Jennings IG, House CM, Michell BJ, Goodwill KE, Santarsiero BD, Stevens RC, Cotton RGH, Kemp BE. 1999. Structural basis of autoregulation of phenylalnine hydroxylase. Nat Struct Biol 6:442448.
  • Kure S, Hou DC, Ohura T, Iwamoto H, Suzuki S, Sugiyama N, Sakamoto O, Fujii K, Matsubara Y, Narisawa K. 1999. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr 135:375378.
  • Miller MP, Kumar S. 2001. Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet 10:23192328.
  • Scriver CR, Hurtubise M, Konecki D, Phommarinh M, Prevost L, Erlandsen H, Stevens R, Waters PJ, Ryan S, McDonald D, Sarkissian C. 2003. PAHdb 2003: what a locus-specific knowledgebase can do. Hum Mutat 21:333344.
  • Slavotinek AM, Biesecker LG. 2001. Unfolding the role of chaperones and chaperonins in human disease. Trends Genet 17:528535.
  • Spaapen LJ, Bakker JA, Velter C, Loots W, Rubio-Gonzalbo ME, Forget PP, Dorland L, De Koning TJ, Poll-The BT, Ploos van Amstel HK, Bekhof J, Blau N, Duran M. 2001. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates. J Inherit Metab Dis 24:352358.
  • Strickland E, Qu BH, Millen L, Thomas PJ. 1997. The molecular chaperone Hsc70 assists the in vitro folding of the N-terminal nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 272:2542125424.
  • Waters PJ, Parniak MA, Akerman BR, Jones AO, Scriver CR. 1999. Missense mutations in the phenylalanine hydroxylase gene (PAH) can cause accelerated proteolytic turnover of PAH enzyme: a mechanism underlying phenylketonuria. J Inherit Metab Dis 22:208212.
  • Waters PJ, Parniak MA, Akerman BR, Scriver CR. 2000. Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype. Mol Genet Metab 69:101110.
  • Waters PJ. 2003. How PAH gene mutations cause hyperphenylalaninemia, and why mechanism matters: insights from in vitro expression. Hum Mutat 21:357369.